CAS 918348-67-1

BMS-779788

CAS : 918348-67-1

BMS-779788

Degré de pureté : ≥98%

Masse moléculaire : 509.06g/mol

Ref: 54-BUP05933

BMS-779788

CAS : 918348-67-1

BMS-779788 (XL-652) is an LXRα/β partial agonist (IC50: 68/14 nM).

Formule : C₂₈H₂₉ClN₂O₃S

Degré de pureté : 98.65% - 99.24%

Couleur et forme : Solid

Masse moléculaire : 509.06

Ref: TM-T3970

BMS-779788

CAS : 918348-67-1

BMS-779788 is a drug for the treatment of dyslipidemia and other conditions. It has been shown to inhibit the constitutive androstane receptor, which is involved in inflammation and oxidative stress. BMS-779788 also inhibits the synthesis of fatty acids, leading to an increase in the production of high-density lipoprotein cholesterol. This agent has also been shown to be effective against statins-resistant patients with hypercholesterolemia. BMS-779788 is currently being investigated as a potential therapeutic agent for cardiovascular disorders such as atherosclerosis, myocardial infarction, and stroke.

Formule : C₂₈H₂₉ClN₂O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 509.06 g/mol

Ref: 3D-TLB34867